Don’t Fall For A Fractured Truth »

| BHOF in the News, Osteoporosis in the News

NOF, HealthyWomen and Radius health recently launched a new education campaign called “Fractured Truth”. This initiative is intended to help postmenopausal women understand the connection between fractures and osteoporosis, the critical need to be proactive about their bone health, and to recognize the myths that are often associated with this disease. As part of the… Read more »

NOF Response to S. 1688 Bill »

| Advocacy, BHOF in the News

The National Osteoporosis Foundation (NOF), which recently led a letter to Congress signed by over 300 health advocacy groups opposing harmful government interference in the Medicare Part D program, today issued the following statement in response to S. 1688: “It is discouraging that, despite direct opposition from over 300 health advocates, members of Congress have… Read more »

NOF Response to Newly Released Evidence Report on Cost Effectiveness of Anabolic Therapies for Osteoporosis in Postmenopausal Women from the Institute for Clinical and Economic Review (ICER) »

| BHOF in the News, Press Releases

The Institute for Clinical and Economic Review (ICER) recently issued a Final Evidence Report accessing the comparative clinical effectiveness and value of anabolic agents for the treatment of osteoporosis in postmenopausal women, including teriparatide and abaloparatide.  NOF leadership and colleagues representing the National Bone Health Alliance (NBHA) provided input and shared ideas and potential concerns… Read more »

The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay »

| Advocacy, BHOF in the News, Press Releases

Washington, DC (June 13, 2017) – The National Osteoporosis Foundation (NOF), today issued the following statement in response to the Senate HELP hearing “The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay” “During today’s hearing, several Senators raised the idea of allowing for the government to set prices in the… Read more »

Osteoporosis: ACP update treatment guidelines for preventing bone fractures »

| BHOF in the News, Osteoporosis in the News

To reduce the risk of hip and vertebral fractures in women with osteoporosis, physicians should treat them with the bisphosphonates risedronate, alendronate, or zoledronic acid, or alternatively with the biologic agent denosumab. This strong recommendation appears in revised guidelines from the American College of Physicians (ACP) for the prevention of fractures in men and women… Read more »

The NOF’s Methods and Processes for Developing Position Statements »

| BHOF in the News, Osteoporosis in the News, Press Releases

The National Osteoporosis Foundation frequently publishes position statements for the benefit of educating healthcare professionals and the general public on a particular issue and/or concern related to preventing osteoporosis and/or promoting strong bones throughout the lifespan. This manuscript represents the official methods and processes adopted by the NOF Board of Trustees for the purpose developing… Read more »

CMS Proposes New Fee Schedules for 2017 »

| BHOF in the News, Osteoporosis in the News

On July 14, 2016, the Centers for Medicare and Medicaid Services (CMS) published the proposed rule for the Hospital Outpatient Prospective Payment System  (HOPPS) for 2017. CMS has proposed to cut the reimbursement rate for Axial DXA, CPT 77080 in the hospital setting from the current national average of $100.69 to $63.33. This reimbursement cut will… Read more »

NOF and ASPC Position Statement on Calcium and Cardiovascular Disease »

| BHOF in the News

The National Osteoporosis Foundation frequently publishes position statements for the benefit of educating healthcare professionals and the general public on a particular issue and/or concern related to preventing osteoporosis and/or promoting strong bones throughout the lifespan. As part of NOF’s Methods and Processes for Developing Position Statements, we welcome public input and comments to the… Read more »

Fearing Drugs’ Rare Side Effects, Millions Take Their Chances With Osteoporosis »

| BHOF in the News, Osteoporosis in the News

Millions of Americans are missing out on a chance to avoid debilitating fractures from weakened bones, researchers say, because they are terrified of exceedingly rare side effects from drugs that can help them.  Last month, the American Society for Bone and Mineral Research, the National Osteoporosis Foundation and the National Bone Health Alliance put out… Read more »